ARDXFeb 20, 2026-14.99% since signalArdelyx Lead Drug Growth Fails To Lift Sentiment, Stock DropsArdelyx Inc. (ARDX) shares fell following an unfavorable financial update for Q4 2025. The outlook suggests potential concerns that may lead to selling pressure in the near term.View signal analysis →